Leonardo Maestri Teixeria
Leonardo Teixeira is a co-founder of Endpoint Health, a precision medicine startup focused in intensive care. Prior to founding Endpoint Health, Leo was a Research Director at Roche Diagnostics, where he led the Research and early development of the next-generation platform from GeneWEAVE biosciences after the acquisition by Roche. Leo Co-Founded GeneWEAVE Biosciences, an IVD company focused on creating diagnostic systems to rapidly detect and guide antibiotic selection for serious infections. GeneWEAVE raised a total of $25M and was acquired by Roche in 2015 in a deal valued at $425M USD.
Leo received his B.S. and M.S. from Universidade Federal de Vicosa in Brazil, and his PhD from Cornell University.